US3965256A
(en)
|
1972-05-16 |
1976-06-22 |
Synergistics |
Slow release pharmaceutical compositions
|
IE49324B1
(en)
|
1979-12-19 |
1985-09-18 |
Euro Celtique Sa |
Controlled release compositions
|
US4457933A
(en)
|
1980-01-24 |
1984-07-03 |
Bristol-Myers Company |
Prevention of analgesic abuse
|
US4987136A
(en)
|
1982-03-16 |
1991-01-22 |
The Rockefeller University |
Method for controlling gastrointestinal dysmotility
|
HU190619B
(en)
|
1983-11-11 |
1986-09-29 |
Bezzegh,Denes,Hu |
Process for producing tablets with controlled dissolution of active ingredients
|
EP0164669B1
(de)
|
1984-06-13 |
1991-01-23 |
Röhm Gmbh |
Verfahren zum Überziehen von Arzneiformen
|
US4785000A
(en)
|
1986-06-18 |
1988-11-15 |
The Rockefeller University |
Method of treating patients suffering from chronic pain or chronic cough
|
US4769372A
(en)
|
1986-06-18 |
1988-09-06 |
The Rockefeller University |
Method of treating patients suffering from chronic pain or chronic cough
|
US5004613A
(en)
|
1987-07-27 |
1991-04-02 |
Mcneil-Ppc, Inc. |
Oral sustained release pharmaceutical formulation and process
|
FR2653337B1
(fr)
|
1989-10-23 |
1992-02-07 |
Dow Corning Sa |
Element a liberation prolongee et procede pour le fabriquer.
|
JPH03232814A
(ja)
|
1990-02-08 |
1991-10-16 |
Shin Etsu Chem Co Ltd |
徐放性錠剤の製造方法
|
DE4325465B4
(de)
|
1993-07-29 |
2004-03-04 |
Zenz, Michael, Prof. Dr.med. |
Orales pharmazeutisches Präparat für die Schmerztherapie
|
US5662933A
(en)
|
1993-09-09 |
1997-09-02 |
Edward Mendell Co., Inc. |
Controlled release formulation (albuterol)
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
DE4443105C2
(de)
|
1994-12-03 |
1997-03-13 |
Hoechst Ag |
Verfahren zur Herstellung Molsidomin-haltiger Tabletten
|
US6488961B1
(en)
|
1996-09-20 |
2002-12-03 |
Ethypharm, Inc. |
Effervescent granules and methods for their preparation
|
DE19651551C2
(de)
|
1996-12-11 |
2000-02-03 |
Klinge Co Chem Pharm Fab |
Opioidantagonisthaltige galenische Formulierung
|
WO1998035679A1
(de)
|
1997-02-14 |
1998-08-20 |
Gödecke Aktiengesellschaft |
Stabilisierung von naloxonhydrochlorid
|
EP1009387B1
(en)
|
1997-07-02 |
2006-04-12 |
Euro-Celtique S.A. |
Stabilized sustained release tramadol formulations
|
EP0913152B1
(de)
|
1997-11-03 |
2001-12-19 |
Stada Arzneimittel Ag |
Stabilisiertes Kombinationsarzneimittel enthaltend Naloxone und ein Opiatanalgetikum
|
ATE323491T1
(de)
|
1997-12-22 |
2006-05-15 |
Euro Celtique Sa |
Peroral zu verabreichende arzneiform enthaltend eine kombination von einem opioid agonisten und naltrexon
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
TWI223598B
(en)
|
1998-06-22 |
2004-11-11 |
Pfizer Ireland Pharmaceuticals |
An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
|
US6071952A
(en)
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
JP2003513045A
(ja)
|
1999-11-01 |
2003-04-08 |
ロデバ・リミテッド |
便秘及び過敏性大腸症候群を治療・処置するための組成物
|
DE10003757A1
(de)
|
2000-01-28 |
2001-08-02 |
Knoll Ag |
Ibuprofen-Wirkstoffzubereitung
|
US6716449B2
(en)
|
2000-02-08 |
2004-04-06 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
DK2283842T3
(en)
|
2000-02-08 |
2015-05-26 |
Euro Celtique Sa |
Oral opioid agonist formulations secured against forgery
|
US20040115133A1
(en)
|
2000-05-10 |
2004-06-17 |
Wermeling Daniel P. |
Intranasal opioid compositions
|
GB0102342D0
(en)
|
2001-01-30 |
2001-03-14 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
ATE493130T1
(de)
|
2001-05-11 |
2011-01-15 |
Endo Pharmaceuticals Inc |
Opioid enthaltende arzneiform gegen missbrauch
|
CA2778114A1
(en)
|
2001-05-11 |
2002-11-21 |
Endo Pharmaceuticals, Inc. |
Abuse-resistant opioid dosage form
|
JP2004534056A
(ja)
|
2001-06-08 |
2004-11-11 |
エンドー ファーマシューティカルズ, インコーポレイティド |
アクリルポリマーを使用する制御放出投薬形態、およびそれを作製するためのプロセス
|
KR20040060917A
(ko)
|
2001-08-06 |
2004-07-06 |
유로-셀티크 소시에떼 아노뉨 |
오피오이드 남용을 방지하기 위한 조성물 및 방법
|
US7332182B2
(en)
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
PT1414451E
(pt)
|
2001-08-06 |
2009-07-31 |
Euro Celtique Sa |
Formulações agonistas de opióides com antagonista libertável e sequestrado
|
BRPI0211899B8
(pt)
|
2001-08-23 |
2021-05-25 |
Akzo Nobel Nv |
processos para a preparação de um derivado de 14- hidroxinormorfinona e para a produção de noroximorfona
|
DE10144726B4
(de)
|
2001-09-11 |
2006-10-05 |
T-Mobile Deutschland Gmbh |
Verfahren zur Bereitstellung und Zuteilung von Rufnummern in einem Telekommunikationsnetz
|
DE10146275A1
(de)
|
2001-09-18 |
2003-04-24 |
Gruenenthal Gmbh |
Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
|
CA2478558C
(en)
|
2002-03-14 |
2012-09-11 |
Euro-Celtique, S.A. |
Naltrexone hydrochloride compositions
|
ES2627298T3
(es)
|
2002-04-05 |
2017-07-27 |
Mundipharma Pharmaceuticals S.L. |
Preparación farmacéutica que contiene oxicodona y naloxona
|
DE10215131A1
(de)
|
2002-04-05 |
2003-10-16 |
Euro Celtique Sa |
Matrix zur verzögerten, gleichbleibenden und unabhängigen Freisetzung von Wirkstoffen
|
WO2004004683A1
(en)
|
2002-07-04 |
2004-01-15 |
Janssen Pharmaceutica N.V. |
Solid dispersions comprising two different polymer matrixes
|
WO2004091665A1
(en)
|
2003-04-08 |
2004-10-28 |
Progenics Pharmaceuticals, Inc. |
Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist
|
US20050004155A1
(en)
|
2003-04-08 |
2005-01-06 |
Boyd Thomas A. |
Use of methylnaltrexone to treat irritable bowel syndrome
|
DK2368553T3
(en)
|
2003-04-08 |
2015-02-09 |
Progenics Pharm Inc |
Pharmaceutical preparation comprising methylnaltrexone
|
CL2004000927A1
(es)
|
2003-04-30 |
2005-01-28 |
Purdue Pharma Lp |
Forma de dosificacion transdermica que comprende un agente activo, una superficie proxima y una superficie distal.
|
US9114199B2
(en)
|
2003-07-31 |
2015-08-25 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices containing acrylic copolymer for controlled delivery of therapeutic agent
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US20050074493A1
(en)
|
2003-10-03 |
2005-04-07 |
Mehta Atul M. |
Extended release formulations of opioids and method of use thereof
|
US20050079221A1
(en)
|
2003-10-10 |
2005-04-14 |
Groenewoud Pieter Jurjen |
Ibuprofen narcotic composition and method for making same
|
US20050232987A1
(en)
|
2004-03-12 |
2005-10-20 |
Viswanathan Srinivasan |
Dosage form containing a morphine derivative and another drug
|
US20050165038A1
(en)
|
2004-01-22 |
2005-07-28 |
Maxwell Gordon |
Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects
|
PT1711502E
(pt)
|
2004-02-06 |
2008-11-20 |
Euro Celtique Sa |
Processos para a produção de morfinonas protegidas em 3-0 e carboxilatos de dienol e morfinonas protegidas em 3-0
|
TWI350762B
(en)
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
US9016221B2
(en)
|
2004-02-17 |
2015-04-28 |
University Of Florida Research Foundation, Inc. |
Surface topographies for non-toxic bioadhesion control
|
TWI365880B
(en)
|
2004-03-30 |
2012-06-11 |
Euro Celtique Sa |
Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone and oxycodone hydrochloride composition,pharmaceutical dosage form,sustained release oeal dosage form and pharmaceutically acceptable package having less than 25 pp
|
US7700626B2
(en)
|
2004-06-04 |
2010-04-20 |
Adolor Corporation |
Compositions containing opioid antagonists
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
EP1604667A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
GB2418854B
(en)
|
2004-08-31 |
2009-12-23 |
Euro Celtique Sa |
Multiparticulates
|
JP2006076971A
(ja)
|
2004-09-13 |
2006-03-23 |
Basf Ag |
口腔内崩壊錠
|
US20060088594A1
(en)
|
2004-10-08 |
2006-04-27 |
Pilgaonkar Pratibha S |
Highly compressible controlled delivery compositions of metformin
|
GB0423103D0
(en)
|
2004-10-19 |
2004-11-17 |
Boots Healthcare Int Ltd |
Therapeutic agents
|
CN101137378A
(zh)
|
2005-01-20 |
2008-03-05 |
普罗热尼奇制药公司 |
甲基纳曲酮和相关化合物治疗术后胃肠功能障碍的用途
|
AP2274A
(en)
|
2005-01-28 |
2011-08-19 |
Euro Celtiques Sa |
Alcohol resistant dosage forms.
|
EP1695700A1
(en)
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
JP2008531605A
(ja)
|
2005-03-04 |
2008-08-14 |
インテルジェネクス コーポレイション |
遅延放出性医薬品経口剤、及びその作製方法
|
JP4741865B2
(ja)
|
2005-03-24 |
2011-08-10 |
共和薬品工業株式会社 |
ペルゴリド錠剤の製造方法
|
US20070026025A1
(en)
|
2005-04-12 |
2007-02-01 |
Aquegel Cosmetics, Llc |
Topical ointment and method for making and using same
|
WO2006125774A1
(en)
|
2005-05-25 |
2006-11-30 |
Janssen Pharmaceutica N.V. |
Pediatric formulation of topiramate
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
WO2007013047A2
(en)
|
2005-07-29 |
2007-02-01 |
Ranbaxy Laboratories Limited |
Water-dispersible anti-retroviral pharmaceutical compositions
|
US20070048364A1
(en)
|
2005-08-04 |
2007-03-01 |
Yingxu Peng |
Free flowing granules containing carbomer
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
PL1962808T3
(pl)
|
2005-12-14 |
2011-03-31 |
Hoffmann La Roche |
Preparat proleku przeciw HCV
|
US20070141147A1
(en)
|
2005-12-21 |
2007-06-21 |
Auriga Laboratories, Inc. |
Sequential release pharmaceutical formulations
|
EP1813276A1
(en)
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
US7799790B2
(en)
|
2006-07-20 |
2010-09-21 |
Helm Ag |
Amorphous aripiprazole and process for the preparation thereof
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
DE102006051020A1
(de)
|
2006-10-26 |
2008-04-30 |
Evonik Röhm Gmbh |
Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
|
GB2447898B
(en)
|
2007-03-24 |
2011-08-17 |
Reckitt Benckiser Healthcare |
A tablet having improved stability with at least two actives
|
JP5406288B2
(ja)
|
2008-07-07 |
2014-02-05 |
ユーロ−セルティーク エス.エイ. |
尿閉を治療するためのオピオイド拮抗薬の使用
|
US20110165232A1
(en)
|
2008-09-16 |
2011-07-07 |
Ak Kimya Ithalat-Ihracat Ve Sanayii Anonim Sirketi |
Use of Opioid Antagonists for the Preparation of a Medicament in the Treatment of Retinal Degenerative Diseases
|
CA2734333A1
(en)
|
2008-09-16 |
2010-03-25 |
Nektar Therapeutics |
Pegylated opioids with low potential for abuse
|
RU2523896C2
(ru)
|
2008-09-18 |
2014-07-27 |
ПУРДЬЮ ФАРМА Эл.Пи. |
Фармацевтические лекарственные формы, содержащие поли-(эпсилон-капролактон)
|
SI2341899T1
(sl)
|
2008-09-24 |
2015-04-30 |
Evonik Roehm Gmbh |
Od pH odvisen opioidni farmacevtski sestavek z nadzorovanim sproščanjem z odpornostjo na vpliv etanola
|
KR101535701B1
(ko)
|
2008-09-24 |
2015-07-09 |
에보니크 룀 게엠베하 |
에탄올의 영향에 대하여 내성을 갖는 비-오피오이드용 ph-의존성 조절 방출 제약 조성물
|
SI2352494T1
(sl)
|
2008-10-30 |
2019-12-31 |
Gruenenthal Gmbh |
Nove in potentne dozirne oblike tapentadola
|
US20100143486A1
(en)
|
2008-12-10 |
2010-06-10 |
Nipun Davar |
Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same
|
CA2750144C
(en)
|
2008-12-31 |
2016-10-25 |
Upsher-Smith Laboratories, Inc. |
Opioid-containing oral pharmaceutical compositions and methods
|
WO2010081034A2
(en)
|
2009-01-09 |
2010-07-15 |
President And Fellows Of Harvard College |
Fluorine containing compounds and methods of use thereof
|
EP2389159A1
(en)
|
2009-01-22 |
2011-11-30 |
Noramco, Inc. |
Process for preparing particles of opioids and compositions produced thereby
|
EP2393487B1
(en)
|
2009-02-06 |
2016-11-02 |
Egalet Ltd. |
Pharmaceutical compositions resistant to abuse
|
EP2398808B1
(en)
|
2009-02-17 |
2013-11-20 |
Mallinckrodt LLC |
Process for the reductive alkylation of normorphinans
|
CN102325777B
(zh)
|
2009-02-23 |
2015-08-12 |
马林克罗特公司 |
(+)-吗啡喃*n-氧化物及其制备方法
|
CN102325776A
(zh)
|
2009-02-23 |
2012-01-18 |
马林克罗特公司 |
(+)-吗啡喃*季盐及其制备方法
|
US20100227876A1
(en)
|
2009-03-06 |
2010-09-09 |
Rechfensen Llp |
Methods of Reducing Side Effects of Analgesics
|
KR20110133602A
(ko)
|
2009-03-10 |
2011-12-13 |
유로-셀티큐 에스.에이. |
옥시코돈 및 날록손을 포함하는 즉시 방출 제약 조성물
|
PL2408436T3
(pl)
|
2009-03-18 |
2017-08-31 |
Evonik Röhm Gmbh |
Kompozycja farmaceutyczna o kontrolowanym uwalnianiu z odpornością na wpływ etanolu, wykorzystująca powłokę zawierającą neutralne polimery winylowe i zaróbki
|
CN102365083A
(zh)
|
2009-03-18 |
2012-02-29 |
赢创罗姆有限公司 |
采用包含聚合物混合物和赋形剂的包衣的具有耐乙醇影响的控释药物组合物
|
EP2413937A1
(en)
|
2009-04-02 |
2012-02-08 |
Shire LLC |
Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
|
US20120065179A1
(en)
|
2009-04-14 |
2012-03-15 |
YKI, Ytemiska Institutet AB |
Prodrug comprising beta-keto carboxylic acid, beta-keto carboxylic acid salt or beta-keto carboxylic acid ester for drug delivery
|
US20100291151A1
(en)
|
2009-04-21 |
2010-11-18 |
Auspex Pharmaceuticals, Inc. |
1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor
|
EP2421507B1
(en)
|
2009-04-24 |
2019-01-23 |
Fertin Pharma A/S |
Chewing gum and particulate material for controlled release of active ingredients
|
WO2010141505A1
(en)
|
2009-06-01 |
2010-12-09 |
Protect Pharmaceutical Corporation |
Abuse-resistant delivery systems
|
GB0909680D0
(en)
|
2009-06-05 |
2009-07-22 |
Euro Celtique Sa |
Dosage form
|
CN102803267A
(zh)
|
2009-06-11 |
2012-11-28 |
马林克罗特有限公司 |
通过催化氢转移的6-α-氨基N-取代的吗啡喃的制备
|
FR2946533A1
(fr)
|
2009-06-12 |
2010-12-17 |
Ethypharm Sa |
Reduction des fluctuations plasmatiques d'opioides.
|
US8829020B2
(en)
|
2009-07-16 |
2014-09-09 |
Mallinckrodt Llc |
Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
|
CN102573805A
(zh)
|
2009-07-22 |
2012-07-11 |
格吕伦塔尔有限公司 |
热熔挤出的控制释放剂型
|
WO2011009604A1
(en)
|
2009-07-22 |
2011-01-27 |
Grünenthal GmbH |
Oxidation-stabilized tamper-resistant dosage form
|
GB0914338D0
(en)
|
2009-08-17 |
2009-09-30 |
Johnson Matthey Plc |
Improved process
|
SG179026A1
(en)
|
2009-09-08 |
2012-04-27 |
Signature Therapeutics Inc |
Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
|
US20110077222A1
(en)
|
2009-09-30 |
2011-03-31 |
Mallinckrodt Inc. |
Sustained-Release Opiate and Opiate Derivative Compositions
|
US8901113B2
(en)
|
2009-09-30 |
2014-12-02 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
US20110150989A1
(en)
|
2009-12-22 |
2011-06-23 |
Mallinkckrodt Inc. |
Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
|
US8597681B2
(en)
|
2009-12-22 |
2013-12-03 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
CN102111808B
(zh)
|
2009-12-25 |
2012-04-25 |
华为技术有限公司 |
一种报告缓存数据量的方法及装置
|
AU2011252040C1
(en)
|
2010-05-10 |
2015-04-02 |
Euro-Celtique S.A. |
Manufacturing of active-free granules and tablets comprising the same
|
PE20130657A1
(es)
*
|
2010-05-10 |
2013-06-15 |
Euro Celtique Sa |
Composiciones farmaceuticas que comprenden hidromorfona y naloxona
|
WO2011141490A1
(en)
|
2010-05-10 |
2011-11-17 |
Euro-Celtique S.A. |
Combination of active loaded granules with additional actives
|
NZ606123A
(en)
|
2010-08-13 |
2015-03-27 |
Euro Celtique Sa |
Use of binders for manufacturing storage stable formulations
|
GB201020895D0
(en)
|
2010-12-09 |
2011-01-26 |
Euro Celtique Sa |
Dosage form
|
US20140037729A1
(en)
*
|
2010-12-28 |
2014-02-06 |
Euro-Celtique, S.A. |
Combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease
|
CN103998025A
(zh)
|
2011-10-06 |
2014-08-20 |
格吕伦塔尔有限公司 |
包含阿片样物质激动剂和阿片样物质拮抗剂的防篡改口服药物剂型
|
CA2881144A1
(en)
|
2012-11-09 |
2014-05-09 |
Purdue Pharma |
Pharmaceutical compositions comprising hydromorphone and naloxone
|
DE112014005175T5
(de)
|
2013-11-13 |
2016-07-21 |
Euro-Celtique S.A. |
Hydromorphon und Naloxon für die Behandlung von Schmerzen und Opioid-Darm-Dysfunktions-Syndrom
|